関連する実験動画

Updated: Jul 9, 2026

Murine Lymphocyte Labeling by 64Cu-Antibody Receptor Targeting for In Vivo Cell Trafficking by PET/CT
11:34

Murine Lymphocyte Labeling by 64Cu-Antibody Receptor Targeting for In Vivo Cell Trafficking by PET/CT

Published on: April 29, 2017

ネズミのTリンパ球サブセットに特異的なモノクローナル抗体による混合リンパ球応答の抑制

M Webb, D W Mason, A F Williams

    Nature
    |December 20, 1979
    PubMed
    まとめ

    特定のラットTリンパ球抗原を標的にするモノクローナル抗体は,混合リンパ球応答 (MLR) を抑制することができます. これは,細胞表面抗原がリンパ球の機能に役割を果たしていることを示唆しています.

    さらに関連する動画

    Functionalization of Atomic Force Microscope Cantilevers with Single-T Cells or Single-Particle for Immunological Single-Cell Force Spectroscopy10:06

    Functionalization of Atomic Force Microscope Cantilevers with Single-T Cells or Single-Particle for Immunological Single-Cell Force Spectroscopy

    Published on: July 10, 2019

    Studying Interactions between Myeloid Cells and CAR T Cells In Vitro and In Vivo05:14

    Studying Interactions between Myeloid Cells and CAR T Cells In Vitro and In Vivo

    Published on: July 25, 2025

    関連する概念動画

    Cell-mediated Immune Responses01:40

    Cell-mediated Immune Responses

    Overview
    Hybridoma Technology01:31

    Hybridoma Technology

    Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
    Hybridoma Selection
    Commonly used fusion techniques — electroporation, polyethylene glycol...